Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, superseding the previous v3.6.2 and signaling an updated version of the study record.SummaryDifference0.1%

- Check26 days agoChange DetectedThe revision label on the page updated from v3.6.0 to v3.6.2, representing a minor version update to the interface; no study content or important functionality changes are indicated.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded recruitment status No longer looking for participants and a new revision tag v3.6.0. The earlier revision v3.5.5 was removed from the history.SummaryDifference0.2%

- Check48 days agoChange DetectedThe history now shows a new latest revision labeled v3.5.5, with the previous v3.5.4 removed from the record. This update changes the page's revision metadata rather than the study content or results.SummaryDifference0.1%

- Check69 days agoChange DetectedVersion 53 (v3.5.4) was released on 2026-05-13. It adds Contacts/Locations and Study Status sections to the study record history.SummaryDifference0.3%

- Check90 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, reflecting a backend or platform update rather than a change to the clinical trial record information.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.